Analyst Research Report Snapshot

Title:

Alfresa Holdings Corporation

Price:

$175.00

Provider:

MarketLine (a Datamonitor Company)

Date:

08 Apr 2014

Pages:

31

Type:

AcrobatPDF

Companies referenced:

2784.T

Available for Immediate Download
Summary:

Alfresa Holdings Corporation - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company. Features: - Detailed information on Alfresa Holdings Corporation required for business and competitor intelligence needs - A study of the major internal and external factors affecting Alfresa Holdings Corporation in the form of a SWOT analysis - An in-depth view of the business model of Alfresa Holdings Corporation including a breakdown and examination of key business segments - Intelligence on Alfresa Holdings Corporation’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Alfresa Holdings Corporation, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Alfresa Holdings Corporation (Alfresa or 'the group') is engaged in the management of subsidiaries that deal with the wholesaling, manufacturing, marketing and import and export of pharmaceuticals, diagnostic reagents and medical devices and equipment. The group primarily operates in Japan, where it is headquartered in Tokyo. It employed 10,939 people as of March 31, 2013. The group recorded revenues of JPY2,387,511 million (approximately $28,888.9 million) during the financial year ended March 2013 (FY2013), an increase of 2.3% over FY2012. The operating profit of the group was JPY23,547 million (approximately $284.9 million) in FY2013, as compared to an operating profit of JPY9,378 (approximately $113.47 million) over FY2012. The net profit was JPY20,771 million (approximately $251.3 million) in FY2013, as compared to a net profit of JPY6,604 (approximately $79.91 million) over FY2012. Reasons to Purchase: - Gain understanding of Alfresa Holdings Corporation and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Alfresa Holdings Corporation as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Alfresa Holdings Corporation’s business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.